Compare BDX & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDX | IDXX |
|---|---|---|
| Founded | 1897 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5B | 57.1B |
| IPO Year | 1994 | 1996 |
| Metric | BDX | IDXX |
|---|---|---|
| Price | $161.41 | $587.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $189.60 | ★ $715.00 |
| AVG Volume (30 Days) | ★ 2.2M | 414.1K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.59% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | 1.34 | ★ 13.08 |
| Revenue | ★ $21,840,000,000.00 | $4,303,702,000.00 |
| Revenue This Year | N/A | $10.83 |
| Revenue Next Year | $2.53 | $8.60 |
| P/E Ratio | $121.13 | ★ $45.24 |
| Revenue Growth | 8.24 | ★ 10.42 |
| 52 Week Low | $158.20 | $356.25 |
| 52 Week High | $231.82 | $769.98 |
| Indicator | BDX | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 27.90 | 36.29 |
| Support Level | N/A | $516.46 |
| Resistance Level | $177.73 | $657.26 |
| Average True Range (ATR) | 3.82 | 17.93 |
| MACD | -0.54 | -3.62 |
| Stochastic Oscillator | 13.34 | 20.17 |
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.